Paradigm Biopharmaceuticals Limited (PBIGF)
PBIGF Stock Price Chart
Explore Paradigm Biopharmaceuticals Limited interactive price chart. Choose custom timeframes to analyze PBIGF price movements and trends.
PBIGF Company Profile
Discover essential business fundamentals and corporate details for Paradigm Biopharmaceuticals Limited (PBIGF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 May 2019
Employees
—
CEO
Paul John Rennie BSc, Grad Dip, MBM, MSTC
Description
Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.
PBIGF Financial Timeline
Browse a chronological timeline of Paradigm Biopharmaceuticals Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Feb 2026
Earnings released on 29 Jul 2025
Earnings released on 29 Apr 2025
Earnings released on 26 Feb 2025
EPS came in at -$0.01 , while revenue for the quarter reached $5.17K .
Earnings released on 30 Oct 2024
EPS came in at -$0.01 , while revenue for the quarter reached $5.67K .
Earnings released on 30 Aug 2024
EPS came in at -$0.01 , while revenue for the quarter reached $43.87K .
Earnings released on 29 Apr 2024
EPS came in at -$0.01 .
Earnings released on 21 Mar 2024
EPS came in at -$0.11 , while revenue for the quarter reached $866.71K .
Earnings released on 30 Jan 2024
EPS came in at -$0.05 .
Stock split effective on 1 Nov 2023
Shares were split 257 : 250 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2023
EPS came in at -$0.02 , while revenue for the quarter reached $27.93K .
Earnings released on 31 Mar 2023
EPS came in at -$0.02 , while revenue for the quarter reached $14.12K .
Earnings released on 26 Feb 2023
EPS came in at -$0.04 , while revenue for the quarter reached $1.53K .
Earnings released on 31 Dec 2022
EPS came in at -$0.04 , while revenue for the quarter reached $1.61K .
Earnings released on 25 Aug 2022
EPS came in at -$0.02 , while revenue for the quarter reached $12.76K .
Earnings released on 30 Jun 2022
EPS came in at -$0.04 , while revenue for the quarter reached $23.39K .
Earnings released on 23 Feb 2022
EPS came in at -$0.04 , while revenue for the quarter reached $16.35K .
Earnings released on 31 Dec 2021
EPS came in at -$0.08 , while revenue for the quarter reached $32.76K .
Earnings released on 26 Aug 2021
EPS came in at -$0.02 , while revenue for the quarter reached $7.82K .
Earnings released on 30 Jun 2021
EPS came in at -$0.04 , while revenue for the quarter reached $15.43K .
Earnings released on 23 Feb 2021
EPS came in at -$0.03 , while revenue for the quarter reached $196.37K .
Earnings released on 31 Dec 2020
EPS came in at -$0.07 .
PBIGF Stock Performance
Access detailed PBIGF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.